EAN 2020 | TERIKIDS study: teriflunomide in pediatric patients with relapsing MS

Name: TERIKIDS study: teriflunomide in pediatric patients with relapsing MS
Uploaded: 2020-05-24T00:00:00Z
Duration: 2 min 12 s
Description: Tanuja Chitnis, MD, FAAN, Massachusetts General Hospital, Boston, MA, discusses the TERIKIDS trial (NCT02201108) looking at the efficacy and safety of teriflunomide in pediatric patients with relapsing forms of multiple sclerosis (MS). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

Tanuja Chitnis • 24 May 2020

EAN 2020

Multiple Sclerosis and Related Disorders Teriflunomide

TERIKIDS

Tanuja Chitnis, MD, FAAN, Massachusetts General Hospital, Boston, MA, discusses the TERIKIDS trial (NCT02201108) looking at the efficacy and safety of teriflunomide in pediatric patients with relapsing forms of multiple sclerosis (MS). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).